Comprehensive healthcare provider reviews should occur at least every 3-6 months during maintenance, with monitoring of weight, metabolic markers, gastrointestinal tolerance, nutritional status, and safety parameters including kidney function and retinopathy screening for patients with diabetes
Please click here for Prescribing Information and Medication Guide for Ozempic (semaglutide) injection
Semaglutide commonly causes nausea, vomiting, and abdominal discomfort, while ibuprofen and other nonsteroidal anti-inflammatory drugs (NSAIDs) can irritate the stomach lining and increase the risk of gastric ulcers and bleeding
Compounded semaglutide is prepared by a state-licensed compounding pharmacy under physician supervision
When you start taking GLP-1s, there are many new changes to navigate
Semaglutide is a powerful tool for managing type 2 diabetes and obesity, but its important to use it under a doctors guidance